An Open-Label Crenezumab Study in Participants With Alzheimer's Disease

Clinical trial NCT03491150 · TERMINATED

Trial details

NCT number: NCT03491150
Sponsor: Hoffmann-La Roche
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Alzheimer's Disease

Start date: 2018-04-11
Primary completion: 2019-05-31
Enrollment: 149

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.